Target Gene/Pathway Pathway / Gene
Search results
| No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | Disease ID |
|---|---|---|---|---|---|
| 1 | Acute myeloid leukemia 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 2 | Acute myeloid leukemia 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 3 | Alcoholism 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 4 | Alcoholism 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 5 | Alzheimer disease 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 6 | Alzheimer disease 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 7 | Apelin signaling pathway 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 8 | Apelin signaling pathway 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 9 | Apoptosis 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 10 | Apoptosis 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 11 | Autophagy - animal 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 12 | Autophagy - animal 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 13 | Axon guidance 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 14 | Axon guidance 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 15 | B cell receptor signaling pathway 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 16 | B cell receptor signaling pathway 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 17 | Bladder cancer 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 18 | Bladder cancer 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 19 | Breast cancer 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 20 | Breast cancer 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 21 | C-type lectin receptor signaling pathway 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 22 | C-type lectin receptor signaling pathway 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 23 | Cadherin signaling 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 24 | Cadherin signaling 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 25 | cAMP signaling pathway 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 26 | cAMP signaling pathway 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 27 | Cellular senescence 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 28 | Cellular senescence 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 29 | Central carbon metabolism in cancer 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 30 | Central carbon metabolism in cancer 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 31 | cGMP-PKG signaling pathway 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 32 | cGMP-PKG signaling pathway 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 33 | Chemical carcinogenesis - reactive oxygen species 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 34 | Chemical carcinogenesis - reactive oxygen species 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 35 | Chemical carcinogenesis - receptor activation 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 36 | Chemical carcinogenesis - receptor activation 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 37 | Chemokine signaling pathway 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 38 | Chemokine signaling pathway 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 39 | Choline metabolism in cancer 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 40 | Choline metabolism in cancer 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 41 | Chronic myeloid leukemia 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 42 | Chronic myeloid leukemia 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 43 | Colorectal cancer 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 44 | Colorectal cancer 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 45 | Endometrial cancer 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 46 | Endometrial cancer 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 47 | ErbB signaling pathway 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 48 | ErbB signaling pathway 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 49 | Estrogen signaling pathway 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 50 | Estrogen signaling pathway 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 51 | Fc epsilon RI signaling pathway 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 52 | Fc epsilon RI signaling pathway 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 53 | Fc gamma R-mediated phagosome formation 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 54 | Fc gamma R-mediated phagosome formation 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 55 | Focal adhesion 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 56 | Focal adhesion 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 57 | FoxO signaling pathway 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 58 | FoxO signaling pathway 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 59 | Gap junction 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 60 | Gap junction 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 61 | Gastric cancer 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 62 | Gastric cancer 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 63 | Glioma 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 64 | Glioma 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 65 | GnRH secretion 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 66 | GnRH secretion 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 67 | GnRH signaling pathway 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 68 | GnRH signaling pathway 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 69 | Growth hormone synthesis, secretion and action 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 70 | Growth hormone synthesis, secretion and action 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 71 | Hepatitis B 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 72 | Hepatitis B 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 73 | Hepatitis C 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 74 | Hepatitis C 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 75 | Hepatocellular carcinoma 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 76 | Hepatocellular carcinoma 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 77 | Human cytomegalovirus infection 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 78 | Human cytomegalovirus infection 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 79 | Human immunodeficiency virus 1 infection 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 80 | Human immunodeficiency virus 1 infection 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 81 | Human papillomavirus infection 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 82 | Human papillomavirus infection 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 83 | Influenza A 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 84 | Influenza A 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 85 | Insulin signaling pathway 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 86 | Insulin signaling pathway 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 87 | JAK-STAT signaling pathway 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 88 | JAK-STAT signaling pathway 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 89 | Kaposi sarcoma-associated herpesvirus infection 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 90 | Kaposi sarcoma-associated herpesvirus infection 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 91 | Long-term depression 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 92 | Long-term depression 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 93 | Long-term potentiation 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 94 | Long-term potentiation 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 95 | MAPK signaling pathway 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 96 | MAPK signaling pathway 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 97 | Melanogenesis 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 98 | Melanogenesis 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 99 | Melanoma 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 100 | Melanoma 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 101 | MicroRNAs in cancer 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 102 | MicroRNAs in cancer 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 103 | mTOR signaling pathway 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 104 | mTOR signaling pathway 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 105 | Natural killer cell mediated cytotoxicity 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 106 | Natural killer cell mediated cytotoxicity 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 107 | Neurotrophin signaling pathway 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 108 | Neurotrophin signaling pathway 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 109 | Neutrophil extracellular trap formation 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 110 | Neutrophil extracellular trap formation 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 111 | Non-small cell lung cancer 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 112 | Non-small cell lung cancer 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 113 | Oxytocin signaling pathway 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 114 | Oxytocin signaling pathway 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 115 | Pancreatic cancer 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 116 | Pancreatic cancer 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 117 | Parathyroid hormone synthesis, secretion and action 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 118 | Parathyroid hormone synthesis, secretion and action 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 119 | Pathways in cancer 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 120 | Pathways in cancer 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 121 | Pathways of neurodegeneration - multiple diseases 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 122 | Pathways of neurodegeneration - multiple diseases 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 123 | PD-L1 expression and PD-1 checkpoint pathway in cancer 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 124 | PD-L1 expression and PD-1 checkpoint pathway in cancer 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 125 | Phospholipase D signaling pathway 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 126 | Phospholipase D signaling pathway 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 127 | PI3K-Akt signaling pathway 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 128 | PI3K-Akt signaling pathway 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 129 | Progesterone-mediated oocyte maturation 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 130 | Progesterone-mediated oocyte maturation 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 131 | Prolactin signaling pathway 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 132 | Prolactin signaling pathway 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 133 | Prostate cancer 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 134 | Prostate cancer 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 135 | Proteoglycans in cancer 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 136 | Proteoglycans in cancer 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 137 | Rap1 signaling pathway 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 138 | Rap1 signaling pathway 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 139 | Ras signaling pathway 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 140 | Ras signaling pathway 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 141 | Regulation of actin cytoskeleton 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 142 | Regulation of actin cytoskeleton 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 143 | Relaxin signaling pathway 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 144 | Relaxin signaling pathway 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 145 | Renal cell carcinoma 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 146 | Renal cell carcinoma 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 147 | Salmonella infection 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 148 | Salmonella infection 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 149 | Serotonergic synapse 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 150 | Serotonergic synapse 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 151 | Signaling pathways regulating pluripotency of stem cells 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 152 | Signaling pathways regulating pluripotency of stem cells 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 153 | Sphingolipid signaling pathway 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 154 | Sphingolipid signaling pathway 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 155 | T cell receptor signaling pathway 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 156 | T cell receptor signaling pathway 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 157 | Thyroid hormone signaling pathway 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 158 | Thyroid hormone signaling pathway 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 159 | Tuberculosis 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 160 | Tuberculosis 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 161 | Vascular smooth muscle contraction 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 162 | Vascular smooth muscle contraction 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 163 | VEGF signaling pathway 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib tosylate Sorafenib tosylate 💬
| Sorafenib | 034 [2] 34, 86 💬
|
| 164 | VEGF signaling pathway 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
RAF1 [1] RAF1 💬
|
Sorafenib Sorafenib 💬
| Sorafenib | 034 [2] 34, 86 💬
|
